$0.98
arrow_drop_up5.41%Key Stats | |
---|---|
Open | $0.93 |
Prev. Close | $0.92 |
EPS | -0.79 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $16.59M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.92 | 0.99 |
52 Week Range | 0.82 | 2.35 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -0.79 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial - GlobeNewswire
Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY - Zacks Investment Research
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Should Risk Averse Traders Buy Penny Stocks?